SYNOVUS FINANCIAL CORP - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 123 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.

Quarter-by-quarter ownership
SYNOVUS FINANCIAL CORP ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,735,113
+7.8%
84,681
+4.6%
0.02%
+11.1%
Q2 2023$1,609,114
+8.7%
80,982
-6.3%
0.02%
+5.9%
Q1 2023$1,479,929
-41.3%
86,394
-33.0%
0.02%
-41.4%
Q4 2022$2,522,850
+80.5%
128,914
+47.7%
0.03%
+70.6%
Q3 2022$1,398,000
+15.7%
87,253
-0.5%
0.02%
+21.4%
Q2 2022$1,208,000
-7.5%
87,661
+6.6%
0.01%0.0%
Q1 2022$1,306,000
-5.4%
82,236
+29.4%
0.01%0.0%
Q4 2021$1,381,000
-5.5%
63,573
+29.8%
0.01%
-6.7%
Q3 2021$1,461,000
-21.7%
48,962
+16.2%
0.02%
-16.7%
Q2 2021$1,867,000
+33.5%
42,138
+33.8%
0.02%
+12.5%
Q1 2021$1,398,000
-47.0%
31,500
-34.5%
0.02%
-46.7%
Q4 2020$2,639,000
+104.7%
48,072
-14.7%
0.03%
+76.5%
Q3 2020$1,289,000
+19.5%
56,385
+9.4%
0.02%
+6.2%
Q2 2020$1,079,000
+0.3%
51,544
-33.2%
0.02%
+6.7%
Q1 2020$1,076,000
+45.4%
77,178
+137.5%
0.02%
+50.0%
Q4 2019$740,00032,5000.01%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
M28 Capital Management LP 715,880$11,354,00010.44%
RTW INVESTMENTS, LP 15,802,802$250,632,0005.19%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 63,000$17,884,0004.03%
TANG CAPITAL MANAGEMENT LLC 1,265,900$20,077,0004.02%
Prosight Management, LP 203,268$3,224,0002.08%
COWEN AND COMPANY, LLC 1,000,000$15,860,0001.53%
Boxer Capital, LLC 1,466,051$23,252,0001.20%
Cormorant Asset Management, LP 868,550$13,775,0001.06%
Amitell Capital Pte Ltd 97,331$1,544,0000.90%
SECTORAL ASSET MANAGEMENT INC 303,975$4,821,0000.86%
View complete list of ROCKET PHARMACEUTICALS INC shareholders